Resources from the same session
1911 - PIK3CA Alterations in Metastatic Breast Cancer (mBC)
Presenter: Joan Albanell
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
4351 - Emergence of ESR1 mutation in cell-free DNA during first line aromatase inhibitor and palbociclib: an exploratory analysis of the PADA-1 trial
Presenter: Francois-Clement Bidard
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
3596 - Updated overall survival (OS) and quality of life (QoL) in premenopausal patients (pts) with advanced breast cancer (ABC) who received ribociclib (RIB) or placebo (PBO) plus goserelin and a nonsteroidal aromatase inhibitor (NSAI) in the MONALEESA-7 (ML-7) trial
Presenter: Yen-Shen Lu
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
5019 - Efficacy and Safety of First China-Manufactured Trastuzumab Biosimilar HLX02 for Metastatic Breast Cancer: A Phase 3 Trial
Presenter: Binghe Xu
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
1216 - The importance of primary surgery in patients with de novo stage IV BC survived at least 5- Year; Protocol MF07-01 Randomized Clinical Trial.
Presenter: Vahit Ozmen
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
2713 - Leuprorelin (LEUP) combined with Letrozole (LET) with/without Everolimus (EVE) in Ovarian suppressed premenopausal women with hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC): Primary analysis of LEO Trial (NCT02344550)
Presenter: Jaeho Jeong
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
Poster Discussion - Breast cancer, metastatic - Invited Discussant 306PD and 307PD
Presenter: Aleix Prat
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Slides
Webcast
1589 - Patient-reported outcomes of palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer from the YoungPearl phase ll trial (KCSG-BR 15-10, NCT02592746)
Presenter: Soohyeon Lee
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract
Poster Discussion - Breast cancer, metastatic - Invited Discussant 309PD and 310PD
Presenter: Sherko Kümmel
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Slides
Webcast
1076 - MONARCHplus: A Phase 3 Trial of Abemaciclib plus Nonsteroidal Aromatase Inhibitor (NSAI) or Fulvestrant (F) for Women with HR+/HER2- Advanced Breast Cancer (ABC)
Presenter: Zefei Jiang
Session: Poster Discussion - Breast cancer, metastatic
Resources:
Abstract